Securities Code: 300289
Stock Abbreviation: Lederman
Announcement Number: 2026-038
Beijing Lederman Biochemical Co., Ltd.
Explanation Regarding Change of Signing Certified Public Accountants for Major Asset Restructuring Project
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
Beijing Lederman Biochemical Co., Ltd. (hereinafter referred to as the "Company" or "Listed Company") intends to acquire 235,040,700 shares of Beijing Sienpharm Biological Products Co., Ltd. (hereinafter referred to as "Sienpharm"), representing 61.50% of Sienpharm's issued shares, by paying cash to Hainan Baimai Investment Co., Ltd., Hainan Sienpharm Baijia Hui Technology Development Co., Ltd., and Nanjing Baijiarui Enterprise Management Consulting Partnership (Limited Partnership) (hereinafter referred to as the "Transaction").
I. Situation Regarding Change of Signing Certified Public Accountants